Back to Results
First PageMeta Content
Oncology / Response Evaluation Criteria in Solid Tumors / Ipilimumab / Rose bengal / Cutaneous leishmaniasis / Medicine / Chemistry / Melanoma


[removed]PV-10: study shows 50% of cutaneous melanoma patients achieve complete response By Janet Fricker
Add to Reading List

Document Date: 2014-06-19 13:59:56

Open Document

File Size: 132,09 KB

Share Result on Facebook

City

Chicago / Bethlehem / /

Company

Provectus / /

Country

United States / Australia / /

Event

FDA Phase / /

Facility

St Luke’s Hospital / Moffitt Cancer Center / /

MedicalCondition

advanced disease / solid tumors / metastatic disease / melanoma / cutaneous melanoma / cutaneous disease / metastatic melanoma / /

Organization

St Luke’s Hospital / American Society of Clinical Oncology / Moffitt Cancer Center Tampa / /

Person

Eric Wachter / Sanjiv Agarwala / Sanjiv S. Agarwala / Janet Fricker / Jeffrey Weber / /

Position

Chief Technology Officer / senior author / /

Product

PV10 injections / PV-10-MM / PV-10 / /

ProvinceOrState

Pennsylvania / Illinois / Florida / /

SocialTag